Developer docs
API playgroundTry for free, no card

Search company profiles

LetsGetChecked

Full company profile

uuid0002f5n

Namestring
LetsGetChecked
Legal namestring
PrivaPath Diagnostics
Company typeenum
Private
Founded yearint
2015
Descriptiontext

LetsGetChecked is a digital health company that operates an integrated at-home diagnostic testing, telehealth consultation, and pharmacy fulfillment platform. Founded in 2015 and headquartered in Ireland (legal entity PrivaPath Diagnostics), the company sells over 30 at-home sample collection kits covering sexual health, cholesterol, thyroid, fertility, diabetes, and other conditions through its e-commerce website and iOS/Android mobile applications. Samples are processed in the company's own CLIA-certified, CAP-accredited laboratory, supported by an FDA-cleared proprietary capillary blood collection device (LetsGetChecked Impress) and ISO 13485-certified manufacturing. The company also operates a virtual care service staffed by board-certified clinicians delivering $49 secure-message consultations across 35+ U.S. states, and a pharmacy service branded as Powered by Fuze Health that delivers prescription medications to patients' homes following the October 2024 acquisition of Truepill for $525 million.

LetsGetChecked pursues a hybrid go-to-market model spanning direct-to-consumer e-commerce, where individual test kits are priced between $89 and $249, and a B2B enterprise sales motion targeting employers, health plans, healthcare providers, and public sector organizations. Named enterprise customers include Amazon, Berkshire Hathaway, Humana, Denver Health, NCSD, and University of Virginia, and the company states it serves over 5,000 organizations. The company has cumulatively processed more than 10 million test kits, served more than 3 million patients, and held a 4.4-star Excellent Trustpilot rating across 18,814 reviews.

The company has raised approximately $448 million in disclosed equity funding across rounds from 2018 through 2025, led at various points by Optum Ventures, Casdin Capital, HLM Venture Partners, and Illumina Ventures, plus $110 million in senior debt in 2023. It is owned by Fuze Health and reports 501-1,000 employees. Recent strategic moves include the Truepill acquisition (2024), the Veritas Genetics and Veritas Intercontinental acquisitions (2022), and an announced but unconsummated BioIQ acquisition (2021). Telehealth availability is limited to 35+ U.S. states, with state-level product restrictions in jurisdictions such as New York.

Short descriptiontext

LetsGetChecked operates an integrated at-home diagnostic testing, telehealth consultation, and pharmacy fulfillment platform serving individual consumers via e-commerce and over 5,000 enterprise organizations including employers, health plans, and providers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home health testing, telemedicine consultations, direct-to-consumer diagnostics, employer wellness programs, online pharmacy services
Industry4 codes
PRIMARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
At-Home Diagnostic Health Testing
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Direct-to-Consumer Health Testing
TypeOne Time License
Description

One-time purchase of at-home health test kits ranging from $89-$249. Tests include sexually transmitted infections (STI), cholesterol, diabetes, thyroid, PCOS, fertility, and more. Samples collected at home and returned to CLIA-certified labs for analysis.

letsgetchecked.com
2Virtual Consultations
TypeSubscription Recurring
Description

$49 per virtual visit with board-certified healthcare providers via secure messaging. Covers assessment, consultation summary, and personalized treatment plan. 72-hour follow-up access included. Separate cost for medication if prescribed.

letsgetchecked.com
3Pharmacy Services
TypeTransaction Fee
Description

Prescription medications delivered to home or sent to local pharmacy. Medications include birth control, erectile dysfunction treatments, thyroid medication (Levothyroxine), weight loss medications (Wegovy, Ozempic, Mounjaro), and STI treatments. Medication cost separate from consultation fee.

letsgetchecked.com
4B2B Enterprise Solutions
TypeSubscription Recurring
Description

Configurable health solutions for employers, health plans, providers, and public sector. Services include cancer screening, women's health and family planning, gaps in care (HEDIS measures), biometric screening, and infectious disease testing programs.

letsgetchecked.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details10 tiers
1Virtual Consultation - General
ModelPer seatBilling cadencePay-as-you-go
Notes

$49 per virtual visit. Includes consultation with board-certified clinician, personalized treatment plan, and 72-hour follow-up access. Medication cost separate.

letsgetchecked.com
2STI Testing - Simple 2
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$99 - Screens for Chlamydia and Gonorrhea only

letsgetchecked.com
3STI Testing - Standard 5
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$149 - Screens for Syphilis, Hepatitis B, Chlamydia, and Trichomoniasis

letsgetchecked.com
4STI Testing - Complete 8
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$249 - Most comprehensive STI screening covering Chlamydia, Gonorrhea, Hepatitis B, Syphilis, Mycoplasma, Ureaplasma, Trichomoniasis, and Gardnerella. Treatment consultation available for $39.

letsgetchecked.com
5Herpes Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$119 - Detects Herpes Simplex I and II antibodies

letsgetchecked.com
6Vaginitis Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$199 - Screens for BV, CV, or TV with treatment options through virtual consultation

letsgetchecked.com
7Hepatitis B & C Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$89 - Fast hepatitis B and C screening

letsgetchecked.com
8Weight Management Consultation
ModelPer seatBilling cadencePay-as-you-go
Notes

$49 per virtual visit for weight management consultations. May include prescription for Wegovy, Ozempic, or Mounjaro if eligible. Medication cost separate.

letsgetchecked.com
9STI Treatment Consultation
ModelPer seatBilling cadencePay-as-you-go
Notes

$39 for virtual consultation if testing positive for STI, to discuss treatment options

letsgetchecked.com
10Cholesterol/Heart Health Treatment
ModelPer seatBilling cadencePay-as-you-go
Notes

$39 virtual consultation for cholesterol treatment options if LDL levels are elevated

letsgetchecked.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Truepill
Description

Digital pharmacy platform that serves as the surviving trade name following LetsGetChecked's acquisition. Truepill provides digital pharmacy and telehealth services integrated into LetsGetChecked's healthcare platform.

businesswire.com
Core offering1 text field

LetsGetChecked is an at-home health testing platform that ships self-collection sample kits (blood, urine, saliva) covering 30+ conditions, processes them in its own CLIA-certified, CAP-accredited laboratory, and returns physician-reviewed results to users through a secure online portal and mobile app. It complements testing with $49 board-certified telehealth consultations and affiliate pharmacy fulfillment (Powered by Fuze Health), creating a complete at-home care pathway from sample collection to medication delivery, sold to individual consumers and configured as enterprise screening programs for 5,000+ organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 10 million health test kits processed
+4 more records
Product and service10 records
1At-Home Health Test Kits
CategoryAt-home diagnostic testing
Description

Self-administered at-home sample collection kits (blood, urine, saliva) covering 30+ health conditions; samples returned by mail to LetsGetChecked's in-house CLIA-certified, CAP-accredited laboratory with results delivered in approximately 2–5 days through a secure online portal and mobile app, intended for individual consumers seeking private, convenient diagnostic testing.

2Virtual Telehealth Consultations
CategoryTelehealth / virtual care
Description

On-demand $49 secure-messaging virtual visit with a board-certified healthcare provider covering 60+ health concerns (sexual health, thyroid, weight management, cold and flu, cholesterol); includes assessment, personalized treatment plan, and 72-hour follow-up access, available in 35+ U.S. states to LetsGetChecked test users and direct consultation patients.

3Pharmacy and Prescription Delivery
CategoryPharmacy / prescription delivery
Description

Affiliate pharmacy service powered by Fuze Health/Truepill that delivers prescribed medications to the patient's home or routes them to a local pharmacy, covering treatments such as birth control, erectile dysfunction medication, Levothyroxine, Wegovy/Ozempic/Mounjaro for weight management, and STI treatments prescribed through LetsGetChecked telehealth visits.

4Enterprise Cancer Screening Solutions
CategoryEnterprise B2B health programs
Description

Configurable at-home cancer screening program for employers, health plans, providers, and public-sector organizations designed to enable early intervention and detection across covered populations.

5Enterprise Women's Health and Family Planning
CategoryEnterprise B2B health programs
Description

Screening and family-planning insights program for women, configurable for employer, health plan, provider, and public-sector clients to support preventive reproductive health decisions.

6Enterprise Gaps-in-Care / HEDIS Program
CategoryEnterprise B2B health programs
Description

Comprehensive gaps-in-care solution for health plans, employers, and providers that uses at-home testing to close HEDIS measure gaps, contain costs, and improve preventive-care compliance across member populations.

7Enterprise Biometric Screening
CategoryEnterprise B2B health programs
Description

Multi-modal biometric screening program for employers, health plans, and providers, including at-home collection of key health metrics to enable a healthier population and workforce wellness reporting.

8Enterprise Infectious Disease Testing
CategoryEnterprise B2B health programs
Description

Discreet at-home infectious disease testing and treatment program with comprehensive STI panels for employer, health plan, provider, and public-sector clients, including follow-up treatment via LetsGetChecked telehealth and pharmacy.

9Enterprise Men's Health Solutions
CategoryEnterprise B2B health programs
Description

Expert-led enterprise men's health program covering conditions commonly affecting men of all ages, configurable for employer, health plan, provider, and public-sector clients.

10LetsGetChecked Impress (Impress)
CategoryDiagnostic device / sample collection technology
Description

FDA-cleared arm-based capillary blood collection device (microtainer fingerstick) for point-of-care clinical diagnostics, used as the proprietary sample collection technology underpinning LetsGetChecked's at-home test kits.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-01
Description

LetsGetChecked completed the acquisition of Truepill in October 2024 for $525 million. Truepill is a digital pharmacy platform that provides telehealth and pharmacy fulfillment services. The merger creates a comprehensive healthcare platform combining LetsGetChecked's home diagnostics with Truepill's digital pharmacy capabilities, enabling seamless care from testing to treatment.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-01
Description

Merger structured as $25M cash, $200M in revenue-linked earnouts, and $150M convertible note totaling stated $525M. Truepill continues as surviving trade name. Deal backed by investor Optum Ventures.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

LetsGetChecked operates as part of Fuze Health, leveraging its pharmacy infrastructure. LetsGetChecked is branded as 'Powered by Fuze Health' on its pharmacy services. Fuze Health provides affiliate pharmacy services for medication delivery and pharmacy support through consultation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

LetsGetChecked was planning to acquire BioIQ (announced November 2021). The acquisition would have expanded LetsGetChecked's at-home testing capabilities and enterprise health solutions offerings. However, this acquisition appears to have been superseded by the Truepill merger.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct-to-consumer at-home health testing company offering a similar catalog of self-collected lab tests (STI, thyroid, hormones, COVID) with telehealth follow-up. Closest competitor to LetsGetChecked's D2C test kit business.

2Ro
TypeDirect peer
Description

Direct-to-consumer telehealth and pharmacy company with verticals in sexual health, fertility, dermatology, and weight management (including compounded GLP-1s). Overlaps with LetsGetChecked's telehealth and pharmacy offering post-Truepill acquisition.

TypeBroad incumbent
Description

Major clinical reference lab with Pixel by Labcorp at-home testing kits and employer health screening programs. Comparable on lab infrastructure, enterprise sales, and home kit channels.

TypeDirect peer
Description

Now an integrated subsidiary rather than a peer; historically a digital pharmacy platform providing telehealth fulfillment and medication delivery, the basis for LetsGetChecked's pharmacy capability.

TypeBroad incumbent
Description

National clinical laboratory network that acquired consumer home-testing provider PWNHealth/HealthtrackRx and offers employer biometric screening. Competes on lab capacity, enterprise contracts, and increasingly on direct-to-consumer home kits.

6Function Health
TypeEmerging player
Description

Subscription at-home lab testing platform offering 100+ biomarkers with longitudinal tracking. Competes in the premium D2C testing segment with a membership model rather than per-kit pricing.

TypeDirect peer
Description

D2C telehealth and pharmacy platform covering sexual health, hair loss, mental health, and weight management with prescription delivery. Comparable in telehealth consultation pricing ($49) and pharmacy fulfillment, and now a direct competitor in GLP-1 weight loss.

TypeEmerging player
Description

At-home genetic and health testing company with FDA-cleared genetic health risk reports. Comparable as a consumer-facing at-home testing brand but focused on genomics rather than clinical lab diagnostics.

9Cue Health
TypeEmerging player
Description

Connected at-home molecular diagnostics platform with FDA-authorized tests. Similar focus on FDA-cleared home diagnostics and connected device approach, though narrower test menu than LetsGetChecked.

TypeBroad incumbent
Description

Large-scale virtual care provider offering general medical, mental health, and chronic condition telehealth. Comparable on telehealth consultation model and enterprise health plan distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LetsGetChecked

At-Home Diagnostic Health Testingletsgetchecked.com

LetsGetChecked operates an integrated at-home diagnostic testing, telehealth consultation, and pharmacy fulfillment platform serving individual consumers via e-commerce and over 5,000 enterprise organizations including employers, health plans, and providers.

What LetsGetChecked does

LetsGetChecked is a digital health company that operates an integrated at-home diagnostic testing, telehealth consultation, and pharmacy fulfillment platform. Founded in 2015 and headquartered in Ireland (legal entity PrivaPath Diagnostics), the company sells over 30 at-home sample collection kits covering sexual health, cholesterol, thyroid, fertility, diabetes, and other conditions through its e-commerce website and iOS/Android mobile applications. Samples are processed in the company's own CLIA-certified, CAP-accredited laboratory, supported by an FDA-cleared proprietary capillary blood collection device (LetsGetChecked Impress) and ISO 13485-certified manufacturing. The company also operates a virtual care service staffed by board-certified clinicians delivering $49 secure-message consultations across 35+ U.S. states, and a pharmacy service branded as Powered by Fuze Health that delivers prescription medications to patients' homes following the October 2024 acquisition of Truepill for $525 million.

LetsGetChecked pursues a hybrid go-to-market model spanning direct-to-consumer e-commerce, where individual test kits are priced between $89 and $249, and a B2B enterprise sales motion targeting employers, health plans, healthcare providers, and public sector organizations. Named enterprise customers include Amazon, Berkshire Hathaway, Humana, Denver Health, NCSD, and University of Virginia, and the company states it serves over 5,000 organizations. The company has cumulatively processed more than 10 million test kits, served more than 3 million patients, and held a 4.4-star Excellent Trustpilot rating across 18,814 reviews.

The company has raised approximately $448 million in disclosed equity funding across rounds from 2018 through 2025, led at various points by Optum Ventures, Casdin Capital, HLM Venture Partners, and Illumina Ventures, plus $110 million in senior debt in 2023. It is owned by Fuze Health and reports 501-1,000 employees. Recent strategic moves include the Truepill acquisition (2024), the Veritas Genetics and Veritas Intercontinental acquisitions (2022), and an announced but unconsummated BioIQ acquisition (2021). Telehealth availability is limited to 35+ U.S. states, with state-level product restrictions in jurisdictions such as New York.

LetsGetChecked firmographics

Firmographics
Name
LetsGetChecked
Legal name
PrivaPath Diagnostics
Website
https://letsgetchecked.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
251–500 employees
Short description
LetsGetChecked operates an integrated at-home diagnostic testing, telehealth consultation, and pharmacy fulfillment platform serving individual consumers via e-commerce and over 5,000 enterprise organizations including employers, health plans, and providers.
Ownership category
akta.pro rank

LetsGetChecked industry classification

Industry
Product category
At-Home Diagnostic Health Testing
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • At-home health testing
  • Telemedicine consultations
  • Direct-to-consumer diagnostics
  • Employer wellness programs
  • Online pharmacy services

Where LetsGetChecked is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

LetsGetChecked business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Direct-to-Consumer Health Testing: One-time purchase of at-home health test kits ranging from $89-$249. Tests include sexually transmitted infections (STI), cholesterol, diabetes, thyroid, PCOS, fertility, and more. Samples collected at home and returned to CLIA-certified labs for analysis.
  2. Virtual Consultations: $49 per virtual visit with board-certified healthcare providers via secure messaging. Covers assessment, consultation summary, and personalized treatment plan. 72-hour follow-up access included. Separate cost for medication if prescribed.
  3. Pharmacy Services: Prescription medications delivered to home or sent to local pharmacy. Medications include birth control, erectile dysfunction treatments, thyroid medication (Levothyroxine), weight loss medications (Wegovy, Ozempic, Mounjaro), and STI treatments. Medication cost separate from consultation fee.
  4. B2B Enterprise Solutions: Configurable health solutions for employers, health plans, providers, and public sector. Services include cancer screening, women's health and family planning, gaps in care (HEDIS measures), biometric screening, and infectious disease testing programs.

Pricing tiers

ModelBillingPrice
Per seatPay-as-you-goVirtual Consultation - General
Unit PricingPay-as-you-goSTI Testing - Simple 2
Unit PricingPay-as-you-goSTI Testing - Standard 5
Unit PricingPay-as-you-goSTI Testing - Complete 8
Unit PricingPay-as-you-goHerpes Test
Unit PricingPay-as-you-goVaginitis Test
Unit PricingPay-as-you-goHepatitis B & C Test
Per seatPay-as-you-goWeight Management Consultation
Per seatPay-as-you-goSTI Treatment Consultation
Per seatPay-as-you-goCholesterol/Heart Health Treatment

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

LetsGetChecked product offering

Product offering

Core offering

LetsGetChecked is an at-home health testing platform that ships self-collection sample kits (blood, urine, saliva) covering 30+ conditions, processes them in its own CLIA-certified, CAP-accredited laboratory, and returns physician-reviewed results to users through a secure online portal and mobile app. It complements testing with $49 board-certified telehealth consultations and affiliate pharmacy fulfillment (Powered by Fuze Health), creating a complete at-home care pathway from sample collection to medication delivery, sold to individual consumers and configured as enterprise screening programs for 5,000+ organizations.

Differentiator

Problem solved

Functional benefit

Brands

  • Truepill: Digital pharmacy platform that serves as the surviving trade name following LetsGetChecked's acquisition. Truepill provides digital pharmacy and telehealth services integrated into LetsGetChecked's healthcare platform.

Products and services

  • At-Home Health Test Kits Self-administered at-home sample collection kits (blood, urine, saliva) covering 30+ health conditions; samples returned by mail to LetsGetChecked's in-house CLIA-certified, CAP-accredited laboratory with results delivered in approximately 2–5 days through a secure online portal and mobile app, intended for individual consumers seeking private, convenient diagnostic testing.
  • Virtual Telehealth Consultations On-demand $49 secure-messaging virtual visit with a board-certified healthcare provider covering 60+ health concerns (sexual health, thyroid, weight management, cold and flu, cholesterol); includes assessment, personalized treatment plan, and 72-hour follow-up access, available in 35+ U.S. states to LetsGetChecked test users and direct consultation patients.
  • Pharmacy and Prescription Delivery Affiliate pharmacy service powered by Fuze Health/Truepill that delivers prescribed medications to the patient's home or routes them to a local pharmacy, covering treatments such as birth control, erectile dysfunction medication, Levothyroxine, Wegovy/Ozempic/Mounjaro for weight management, and STI treatments prescribed through LetsGetChecked telehealth visits.
  • Enterprise Cancer Screening Solutions Configurable at-home cancer screening program for employers, health plans, providers, and public-sector organizations designed to enable early intervention and detection across covered populations.
  • Enterprise Women's Health and Family Planning Screening and family-planning insights program for women, configurable for employer, health plan, provider, and public-sector clients to support preventive reproductive health decisions.
  • Enterprise Gaps-in-Care / HEDIS Program Comprehensive gaps-in-care solution for health plans, employers, and providers that uses at-home testing to close HEDIS measure gaps, contain costs, and improve preventive-care compliance across member populations.
  • Enterprise Biometric Screening Multi-modal biometric screening program for employers, health plans, and providers, including at-home collection of key health metrics to enable a healthier population and workforce wellness reporting.
  • Enterprise Infectious Disease Testing Discreet at-home infectious disease testing and treatment program with comprehensive STI panels for employer, health plan, provider, and public-sector clients, including follow-up treatment via LetsGetChecked telehealth and pharmacy.
  • Enterprise Men's Health Solutions Expert-led enterprise men's health program covering conditions commonly affecting men of all ages, configurable for employer, health plan, provider, and public-sector clients.
  • LetsGetChecked Impress (Impress) FDA-cleared arm-based capillary blood collection device (microtainer fingerstick) for point-of-care clinical diagnostics, used as the proprietary sample collection technology underpinning LetsGetChecked's at-home test kits.

Quantifiable outcome

  • Over 10 million health test kits processed
  • +4 more outcomes

Companies that use LetsGetChecked

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles3 records

LetsGetChecked technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

LetsGetChecked partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • TruepillcoreStrategic or Co-development Partner · 1 October 2024LetsGetChecked completed the acquisition of Truepill in October 2024 for $525 million. Truepill is a digital pharmacy platform that provides telehealth and pharmacy fulfillment services. The merger creates a comprehensive healthcare platform combining LetsGetChecked's home diagnostics with Truepill's digital pharmacy capabilities, enabling seamless care from testing to treatment.
  • TruepillcoreStrategic or Co-development Partner · 1 August 2024Merger structured as $25M cash, $200M in revenue-linked earnouts, and $150M convertible note totaling stated $525M. Truepill continues as surviving trade name. Deal backed by investor Optum Ventures.
  • Fuze HealthcoreOEM/ Whitelabel/ Licensing PartnerLetsGetChecked operates as part of Fuze Health, leveraging its pharmacy infrastructure. LetsGetChecked is branded as 'Powered by Fuze Health' on its pharmacy services. Fuze Health provides affiliate pharmacy services for medication delivery and pharmacy support through consultation.
  • BioIQcoreStrategic or Co-development PartnerLetsGetChecked was planning to acquire BioIQ (announced November 2021). The acquisition would have expanded LetsGetChecked's at-home testing capabilities and enterprise health solutions offerings. However, this acquisition appears to have been superseded by the Truepill merger.

Scale indicators13 records

Recent moves6 records

Expansion highlights7 records

LetsGetChecked competitors and assessment

Company assessment

Direct peers

  • Everlywell: Direct-to-consumer at-home health testing company offering a similar catalog of self-collected lab tests (STI, thyroid, hormones, COVID) with telehealth follow-up. Closest competitor to LetsGetChecked's D2C test kit business.
  • Ro: Direct-to-consumer telehealth and pharmacy company with verticals in sexual health, fertility, dermatology, and weight management (including compounded GLP-1s). Overlaps with LetsGetChecked's telehealth and pharmacy offering post-Truepill acquisition.
  • Truepill (post-acquisition subsidiary): Now an integrated subsidiary rather than a peer; historically a digital pharmacy platform providing telehealth fulfillment and medication delivery, the basis for LetsGetChecked's pharmacy capability.
  • Hims & Hers Health: D2C telehealth and pharmacy platform covering sexual health, hair loss, mental health, and weight management with prescription delivery. Comparable in telehealth consultation pricing ($49) and pharmacy fulfillment, and now a direct competitor in GLP-1 weight loss.

Broad incumbents

  • Labcorp: Major clinical reference lab with Pixel by Labcorp at-home testing kits and employer health screening programs. Comparable on lab infrastructure, enterprise sales, and home kit channels.
  • Quest Diagnostics: National clinical laboratory network that acquired consumer home-testing provider PWNHealth/HealthtrackRx and offers employer biometric screening. Competes on lab capacity, enterprise contracts, and increasingly on direct-to-consumer home kits.
  • Teladoc Health: Large-scale virtual care provider offering general medical, mental health, and chronic condition telehealth. Comparable on telehealth consultation model and enterprise health plan distribution.

Emerging players

  • Function Health: Subscription at-home lab testing platform offering 100+ biomarkers with longitudinal tracking. Competes in the premium D2C testing segment with a membership model rather than per-kit pricing.
  • 23andMe: At-home genetic and health testing company with FDA-cleared genetic health risk reports. Comparable as a consumer-facing at-home testing brand but focused on genomics rather than clinical lab diagnostics.
  • Cue Health: Connected at-home molecular diagnostics platform with FDA-authorized tests. Similar focus on FDA-cleared home diagnostics and connected device approach, though narrower test menu than LetsGetChecked.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

LetsGetChecked social profiles

Digital presence

LetsGetChecked financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LetsGetChecked leadership team

Management profile

Number of profiles

Profiles14 records

LetsGetChecked subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

LetsGetChecked funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LetsGetChecked M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LetsGetChecked

What does LetsGetChecked do?

LetsGetChecked is an at-home health testing platform that ships self-collection sample kits (blood, urine, saliva) covering 30+ conditions, processes them in its own CLIA-certified, CAP-accredited laboratory, and returns physician-reviewed results to users through a secure online portal and mobile app. It complements testing with $49 board-certified telehealth consultations and affiliate pharmacy fulfillment (Powered by Fuze Health), creating a complete at-home care pathway from sample collection to medication delivery, sold to individual consumers and configured as enterprise screening programs for 5,000+ organizations.

Is LetsGetChecked a public or private company?

LetsGetChecked is a private company. It is classified as venture growth investor backed and is currently operating.

When was LetsGetChecked founded?

LetsGetChecked was founded in 2015. It employs 251 to 500 people.

Where is LetsGetChecked based?

LetsGetChecked is headquartered in New York, United States, in the North America region.

How does LetsGetChecked make money?

Four revenue lines are on record. Direct-to-Consumer Health Testing is the primary driver. The others are virtual Consultations, pharmacy Services and B2B Enterprise Solutions.

Who are LetsGetChecked's main competitors?

Direct peers on record are Everlywell, Ro, Truepill (post-acquisition subsidiary) and Hims & Hers Health. Broad incumbents are Labcorp, Quest Diagnostics and Teladoc Health. Emerging players are Function Health, 23andMe and Cue Health.

Does LetsGetChecked have an API?

No public API is recorded for LetsGetChecked.

What industry is LetsGetChecked in?

LetsGetChecked's product category is At-Home Diagnostic Health Testing. Its primary akta.pro industry code is HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits), with a secondary code of HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices). Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogLetsGetChecked Powered by Fuze Health Partners with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to PatientsLetsGetChecked powered by Fuze Health announced the Onclarity HPV Self-Collection Kit, tested with the BD Onclarity HPV Assay, the most comprehensive FDA-cleared at-home HPV screening tool in the U.S. The kit detects 14 high-risk HPV genotypes, addressing screening gaps among unscreened women.ZDNET JapanI read the fine print on at-home DNA and health tests - watch out for these risksA ZDNET investigative review examined the privacy policies and practices of 10 at-home direct-to-consumer (DTC) DNA and health testing companies, finding widespread gaps in HIPAA protections, inconsistent use of regulatory language, and ambiguous data sharing practices with third parties for marketing and research purposes. The investigation revealed that companies like LetsGetChecked, SiPhox, and Nebula Genomics may share de-identified or aggregated genetic data with third parties, while experts warn that supposedly anonymized genomic data can often be re-identified and linked back to individuals. Consumer advocates and bioethicists quoted in the article argue that the industry lacks consistent FDA oversight, that follow-up medical care and genetic counseling vary widely, and that federal laws like GINA do not fully protect consumers from genetic discrimination by life, long-term care, or disability insurers.Think BusinessScaling crunch persists for Irish start-upsIrish start-ups raised €992 million across 319 companies in 2025, a modest increase from 2024. The first quarter saw 69 companies raise €616 million, but the rest of the year saw only €376 million from 250 companies. Scaling capital remains a concern, with four outliers accounting for nearly half of funding.AsmMore than a drop of blood: the paradigm shift of a large-volume capillary sample for point-of-care clinical diagnosticsThe FDA's marketing authorization of the Xpert HCV test, which uses a 100 µL fingerstick blood sample collected into a BD K2EDTA microtainer, has established a precedent for large-volume capillary blood sampling (≥250 µL) in point-of-care diagnostics. Multiple devices now exist for large-volume capillary blood production and collection, including fingerstick-based tools like the BD MiniDraw and arm-based devices such as Tasso+, TAP Lancet, RedDrop ONE, LetsGetChecked Impress, and NanoDrop Lancet, though potassium and platelet measurements remain challenging for arm-based tools. Key regulatory and technical barriers remain, including the need for plasma separation solutions for POC testing and clarification of how these devices can be paired with different POC tests under current FDA frameworks.openPR.comMarket Trend Analysis: The Impact of Emerging Developments on the Telehealth and Telemedicine MarketThe telehealth and telemedicine market is projected to grow to $392.01 billion by 2030, driven by hybrid care models, AI-powered diagnostics, and expanding tele-ICU and telepsychiatry services. In October 2024, Ireland-based LetsGetChecked acquired U.S.-based Truepill for $525 million, combining Truepill's digital pharmacy and telehealth services with LetsGetChecked's home diagnostics platform. Additionally, Pfizer Inc. launched PfizerForAll in August 2024, a free digital health platform connecting patients to telehealth providers, prescription delivery, and diagnostic scheduling services.HoldTelehealth Services Investing Market Research ReportThis market research report examines the telehealth sector's transition from pandemic-era growth to a maturity phase focused on clinical outcomes, unit economics, and integration capabilities, with value migrating toward orchestration platforms rather than basic video visit commoditization. The report documents significant M&A activity including Teladoc's acquisitions of Catapult Health ($65M, Feb 2025) and UpLift ($30M, Apr 2025), LetsGetChecked's purchase of Truepill ($525M, Aug 2024), and Hims & Hers' announced acquisition of ZAVA (Jun 2025), alongside market sizing projections of $123-162B in 2024 growing to $455-791B by 2030. Key risks identified include Medicare telehealth flexibilities expiring January 30, 2026, DEA prescribing rules uncertainty through December 31, 2025, and DTC customer acquisition cost volatility.openPR.comOverview of the At-Home Genetic Testing Market: Key Trends, Market Structure, and Major Player AnalysisThe at-home genetic testing market is projected to reach $8.29 billion by 2030, growing at a compound annual growth rate of 15.5%, driven by advances in technology, digital health integration, and rising demand for personalized healthcare. In February 2025, Tempus AI Inc., a US-based health technology firm, acquired Ambry Genetics Corporation to strengthen its precision medicine capabilities by leveraging Ambry Genetics' expertise in clinical-grade genetic testing and advanced diagnostics. The broader market features numerous companies including AncestryDNA, LetsGetChecked, Helix OpCo LLC, and others driving innovation in ancestry testing, health and wellness insights, and disease risk assessment.openPR.comDirect To Consumer Relationship Tests Market Analysis By Application, Type, Technology, and Geography - Global Industry Outlook and Forecast 2026-2033Market Research Intellect published a market report indicating the global Direct-to-Consumer Relationship Tests market was valued at USD 9.77 billion in 2025 and is projected to grow at a 9.26% CAGR to reach USD 19.85 billion by 2033, compared to USD 2.5 billion in 2022 reflecting a 15% CAGR growth over the preceding five years. The report identifies genetic testing as the dominant segment comprising over 60% of market share, with North America accounting for over 50% of the market driven by favorable regulatory environments and high consumer health literacy. Industry players cited in the report include 23andMe, AncestryDNA, MyHeritage, Everlywell, LetsGetChecked, Zyto, Pathway Genomics, Genetic Health, Invitae, LabCorp, and Quest Diagnostics, alongside key growth drivers such as increasing consumer awareness of personalized health, advancements in genomic sequencing, and the integration of digital health platforms.openPR.comHome Blood Test Market Is Going to Boom |• Everlywell • LetsGetCheckedWorldwide Market Reports released a comprehensive market research study titled "Home Blood Test Market Size and Forecast 2026-2033," providing analysis of market drivers, challenges, opportunities, and competitive landscape for the home blood testing industry.